Aptevo Research And Development LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1999-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.trubion.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of APVO436 in Patients With AML or MDS
Phase 1
- Conditions
- MDSAML
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2022-02-10
- Lead Sponsor
- Aptevo Research and Development LLC
- Target Recruit Count
- 136
- Registration Number
- NCT03647800
- Locations
- 🇺🇸
University of California, San Francisco Medical Center, San Francisco, California, United States
🇺🇸Colorado Blood Cancer Institute, Denver, Colorado, United States
🇺🇸University of Florida College of Medicine, Gainesville, Florida, United States
News
No news found